Lupin receives USFDA approval for Tolvaptan Tablets
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Harnessing advanced data analysis for early detection, prevention and better outcomes
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Subscribe To Our Newsletter & Stay Updated